Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer
1 clinical trials · Condition
◉ Watch Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer
| Record | Firm | Date |
|---|---|---|
| A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC) (NCT07054242) | Yantai Yuhuangding Hospital | 2025-10-30 |
Track Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.